Palliative care should be viewed as a supportive element of care for patients with chronic illnesses at all stages of their disease.
Elevated risks seen across all sociodemographic groups, with particularly high rates for Hispanics, Medicaid-insured, uninsured.
Biochemist, Mark O’Brian, explains that preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.
December FDA approvals include treatments for weight loss in adolescents, major depressive disorder, lung cancer detection, metastatic non-small cell lung cancer, multiple sclerosis, and lymphoma.
Self-reported failure to have understanding of treatment linked to failure to meet treatment expectations.
Vast majority of cancers diagnosed due to symptoms or other medical care.
Implementation of on-site guideline-based genetic testing for prostate cancer patients increased compliance from 33.3% to 98.7%.
Researchers evaluated rates of infection-related and infection-unrelated cancers among younger and older adults with HIV infection.
Experts are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Companies announced that the vaccine performed well in a small study of patients who had melanomasurgically removed
The authors present a case in which genetic testing for breast cancer may have affected outcomes in a 35-year-old woman.
A study sought to determine if mindfulness-based stress reduction would ease compassion fatigue and burnout among the facility’s pediatric oncology nurses.
Recent FDA approvals include treatments for acute low back pain, postoperative nausea and vomiting, multiple myeloma, hemophilia B, and fibromyalgia pain.
Current evidence is insufficient for assessing balance of benefits and harms of screening for asymptomatic teens, adults.
Screening colonoscopy may provide a small reduction in the risk of colorectal cancer and no reduction in the risk of death, a study suggests.
Among women with Medicare insurance, Black women less likely than White women to receive digital versus screen-film mammography, digital breast tomosynthesis.
Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.
A review of the results of the Pathways Heart Study, which sought to identify the link between a history of breast cancer treatment and cardiovascular risks in women.
Researchers sought to determine the survival outcomes of patients with metastatic esophageal cancer who received multimodality treatment, including an operation.
Overall incidence rate 6 times higher for patients aged 40 years or older vs younger than 40 years, but increase in CTCL rate significantly higher for those younger than 40 years.